Syngene International Ltd

NSE :SYNGENE   BSE :539268  Sector : Healthcare
Buy, Sell or Hold SYNGENE? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

06 Sep
899.65
(-0.77%)
05 Sep
906.65
(3.07%)
04 Sep
879.65
(1.22%)
03 Sep
869.05
(0.22%)
02 Sep
867.10
(-0.19%)
30 Aug
868.75
(1.75%)
29 Aug
853.80
(1.20%)
28 Aug
843.70
(2.11%)
27 Aug
826.30
(-3.19%)
26 Aug
853.50
(1.30%)
23 Aug
842.55
(0.06%)
22 Aug
842.05
(0.95%)
21 Aug
834.10
(0.58%)
20 Aug
829.25
(0.52%)
19 Aug
824.95
(-0.72%)
16 Aug
830.95
(1.86%)
14 Aug
815.75
(-1.15%)
13 Aug
825.25
(0.05%)
12 Aug
824.80
(-1.86%)
09 Aug
840.45
(-0.11%)
08 Aug
841.35
(-1.06%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish
Medium Term Investors

Very Bullish
Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bullish

884.34

10 DMA
Bullish

866.93

20 DMA
Bullish

848.98

50 DMA
Bullish

797.75

100 DMA
Bullish

744.06

200 DMA
Bullish

730.95


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Sep 06, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 922.7 916.35 903.69 - -
R2 916.35 910.73 902.35 915.85 -
R1 908 907.27 901 907 912.18
P 901.65 901.65 901.65 901.15 903.74
S1 893.3 896.03 898.3 892.3 897.48
S2 886.95 892.57 896.96 886.45 -
S3 878.6 886.95 895.61 - -

Key Metrics

EPS

11.18

P/E

80.5

P/B

8.64

Dividend Yield

0.14%

Market Cap

36,214 Cr.

Face Value

10

Book Value

104.14

ROE

12.95%

EBITDA Growth

218.9 Cr.

Debt/Equity

0.17

Shareholding Pattern

  54.72% Total Promoter Holding
13.63% Mutual Fund Holdings
20.63% FIIs
7.42% Non Institution
1.95% Insurance Companies
0.43% Custodians
1.22% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Syngene International Ltd Quaterly Results


Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
INCOME 831.7 931.7 882.8 933 839.8
PROFIT 93.4 122.22 114.49 188.6 51.79
EPS 2.33 2.9 2.78 4.7 1.89

Syngene International Ltd Quaterly Results


Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
INCOME 738.7 851.7 820.7 880 776.2
PROFIT 75.3 107.35 102.76 189.8 49.96
EPS 1.88 2.53 2.49 4.73 1.84

Profit & Loss (Figures in Rs. Crores)


Syngene International Ltd Profit & Loss


Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 1498.4 1874.7 2164 2309.1 2678.6 3305.8 3522.6
PROFIT 289.35 328.12 358.49 379.76 417.63 470.41 520.91
EPS 7.64 8.29 10.3 10.12 9.88 11.57 12.69

Syngene International Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 881.9 1117.7 1293.9 1498.4 1874.7 2164 2304.2 2730.6 3306.4 3234.5
PROFIT 175 240.8 286.74 289.05 327.22 357.85 378.54 415.64 470.5 466.99
EPS 7.82 5.92 7.19 7.63 8.27 10.29 10.09 9.83 11.78 11.6

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
SOURCES OF FUNDS :
Share Capital 402401.4400.8400400200200
Reserves Total 3,855.83,216.62,896.82,421.41,775.81,768.41,520.4
Total Shareholders Funds4,257.83,6183,297.62,821.42,175.81,968.41,720.4
Secured Loans 141.7575.3531.5512.4376.7606.6692.6
Unsecured Loans 413.5239.9490.1380.5396.2206.794.8
Total Debt555.2815.21,021.6892.9772.9813.3787.4
Other Liabilities284.5321.6295.6311.2366.7244.899.5
Total Liabilities5,097.54,754.84,614.84,025.53,315.43,026.52,607.3
APPLICATION OF FUNDS :
Gross Block 5,011.64,546.93,943.53,4603,017.22,1711,660.7
Less: Accumulated Depreciation2,161.61,8801,550.71,259997.5794.2630.3
Net Block2,8502,666.92,392.82,2012,019.71,376.81,030.4
Capital Work in Progress838.1176.9346.4237.2234.1273.7155.4
Investments 547.9918.51,034.1702776.4716157.7
Inventories 238.5332.8179.459.625.243.486
Sundry Debtors 441.6529.3507.7475.7398.2338.7266.8
Cash and Bank Balance563.5531.7517.9642.6281.5436.9967.4
Loans and Advances 202.2207.1237.1205.5169.3229.1242.3
Total Current Assets1,445.81,600.91,442.11,383.4874.21,048.11,562.5
Current Liabilities 933.81,010.5866.8797.8794.3640.2555.4
Provisions 120.365.782.259.953.236.826.3
Total Current Liabilities & Provisions1,054.11,076.2949857.7847.5677581.7
Net Current Assets391.7524.7493.1525.726.7371.1980.8
Deferred Tax Assets182.6194.1190.7188.9208.3124.6118.4
Deferred Tax Liability141.9124.5125.199.885.633.146
Net Deferred Tax40.769.665.689.1122.791.572.4
Other Assets429.1398.2282.8270.5135.8197.4210.6
Total Assets5,097.54,754.84,614.84,025.53,315.43,026.52,607.3
Contingent Liabilities1,269.21,243.81,095.6859.6424.7335.9476.8
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 402401.4400.8400400200200200200199.1
Reserves Total 3,789.53,217.52,891.22,418.31,774.11,767.21,520.11,224.4824.7645.8
Equity Application Money0000000-11.300
Total Shareholders Funds4,191.53,618.93,2922,818.32,174.11,967.21,720.11,413.11,024.7844.9
Secured Loans 141.7575.3531.5512.4376.7606.6692.6689.889118.6
Unsecured Loans 190.763.3490.1380.5396.2206.794.8116.60136.4
Total Debt332.4638.61,021.6892.9772.9813.3787.4806.4891155
Other Liabilities281.9319.6295.6311.2366.7244.899.571.671.677.9
Total Liabilities4,805.84,577.14,609.24,022.43,313.73,025.32,6072,291.11,987.31,077.8
APPLICATION OF FUNDS :
Gross Block 4,3714,070.73,943.53,4603,017.22,1711,660.71,331.91,111.4938
Less : Accumulated Depreciation 2,053.11,810.81,550.71,259997.5794.2630.3521.5531.2434.7
Net Block 2,317.92,259.92,392.82,2012,019.71,376.81,030.4810.4580.2503.3
Capital Work in Progress759.6126.2346.4237.2234.1273.7155.4174.9236.8105.1
Investments 927.6940.81,034.4702.3776.7716.3158540.4276.6146
Inventories 234332.8179.459.625.243.48632.237.738.4
Sundry Debtors 427.5484.4508.2474.4398.2338.7266.8198.7185.2179.9
Cash and Bank Balance528.2509.3515.1638.2280.3435.4966.5527.3719.9115.7
Loans and Advances 169.6733.4237.1205.5169.3229.1242.3225.5115.3105.8
Total Current Assets1,359.32,059.91,439.81,377.78731,046.61,561.6983.71,058.1439.8
Current Liabilities 914.11,210.1869.4795.3795.1640.2555.2462.5350.8329.4
Provisions 11460.882.259.853.236.826.221.217.49.4
Total Current Liabilities & Provisions1,028.11,270.9951.6855.1848.3677581.4483.7368.2338.8
Net Current Assets331.2789488.2522.624.7369.6980.2500689.9101
Deferred Tax Assets178.3201.6190.3188.5208.3124.6118.497.284.55.1
Deferred Tax Liability128.5122.1125.299.885.633.14633.512.810
Net Deferred Tax49.879.565.188.7122.791.572.463.771.7-4.9
Other Assets419.7381.7282.3270.6135.8197.4210.6201.7132.1227.3
Total Assets4,805.84,577.14,609.24,022.43,313.73,025.32,6072,291.11,987.31,077.8
Contingent Liabilities1,264.21,243.8547.8859.6849.2671.6238.5376.6384.9110.4

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...510
Depreciation425.9
Interest (Net)-15.2
P/L on Sales of Invest-14.4
Prov. and W/O (Net)-14.8
P/L in Forex-3.6
Total Adjustments (PBT and Ext...475.9
Operating Profit before Workin...985.9
Trade and 0ther Receivables86.7
Inventories114.6
Trade Payables-102.7
Total Adjustments (OP before W...181.3
Cash Generated from/(used in) ...1,167.2
Direct Taxes Paid-125.1
Total Adjustments(Cash Generat...-125.1
Cash Flow before Extraordinary...1,042.1
Net Cash from Operating Activi...1,042.1
Purchased of Fixed Assets-510.8
Sale of Fixed Assets22.1
Purchase of Investments-2,804
Sale of Investments2,735.2
Interest Received81.5
Net Cash used in Investing Act...-494.4
Of the Long Tem Borrowings-390.4
Of the Short Term Borrowings-45.2
Of Financial Liabilities-36.8
Dividend Paid-50.3
Interest Paid-28.8
Net Cash used in Financing Act...-551.5
Net Profit before Tax and Extr...466.5
Depreciation368.9
Interest (Net)-31.6
P/L on Sales of Invest-13
Prov. and W/O (Net)-17.8
P/L in Forex-3.3
Total Adjustments (PBT and Ext...380
Operating Profit before Workin...846.5
Trade and 0ther Receivables58.8
Inventories119.1
Trade Payables-116.6
Total Adjustments (OP before W...165.3
Cash Generated from/(used in) ...1,011.8
Direct Taxes Paid-98.4
Total Adjustments(Cash Generat...-98.4
Cash Flow before Extraordinary...913.4
Net Cash from Operating Activi...913.4
Purchased of Fixed Assets-367.2
Sale of Fixed Assets21.6
Purchase of Investments-2,944
Sale of Investments2,516.4
Interest Received81.2
Net Cash used in Investing Act...-382.6
Of the Long Tem Borrowings-390.4
Of the Short Term Borrowings-45.2
Of Financial Liabilities-32.2
Dividend Paid-50.3
Interest Paid-18.2
Net Cash used in Financing Act...-536.3

Company Details

Registered Office
AddressBiocon SEZ Biocon Park,
Plot No 2 & 3 Bommasandra Inds
CityBengaluru
StateKarnataka
Pin Code560099
Tel. No.91-80-68915000/67758781
Fax. No.91-80-28083189
Emailinvestor@syngeneintl.com; Mayank.Verma@syngeneintl
Internethttp://www.syngeneintl.com
Registrars
AddressBiocon SEZ Biocon Park
CityBengaluru
StateKarnataka
Pin Code560099
Tel. No.91-80-68915000/67758781
Fax. No.91-80-28083189
Emailinvestor@syngeneintl.com; Mayank.Verma@syngeneintl
Internethttp://www.syngeneintl.com
Management
Name Designation
Kiran Mazumdar ShawChairperson
Catherine Patricia RosenbergNon Executive Director
Paul Frederick BlackburnIndependent Director
Vijay KuchrooIndependent Director
Jonathan HuntManaging Director & CEO
Vinita BaliLead Independent Director
Priyadarshnini MahapatraCompany Sec. & Compli. Officer
Sharmila KarveIndependent Director
Kush ParmarIndependent Director
SIBAJI BISWASExecutive Director & CFO
Nilanjan RoyIndependent Director
Manja BoermanIndependent Director